Zobrazeno 1 - 10
of 70
pro vyhledávání: '"E, Recaldin"'
Autor:
Roberto Buzzoni, M. Di Bartolomeo, A Iop, Emilio Bajetta, S Jacobelli, Luigi Mariani, Graziella Pinotti, L. Isa, C. Barone, S. Lo Vullo, Nicoletta Zilembo, Erminia Ferrario, E Recaldin, Enrico Aitini
Publikováno v:
British Journal of Cancer
This randomised phase II study evaluates the safety and efficacy profile of uracil/tegafur/leucovorin combined with irinotecan (TEGAFIRI) or with oxaliplatin (TEGAFOX). One hundred and forty-three patients with measurable, non-resectable metastatic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86861f2422e07b3b9383e33692c85356
https://doi.org/10.1038/sj.bjc.6603493
https://doi.org/10.1038/sj.bjc.6603493
Autor:
F. Recchia, P. Marchei, R. Trevisonne, C. Pizza, S. Chiadò Cutin, M. Tonato, S. Del Prete, G. Vietti Ramus, C. Oliva, T. Iannone, Mario Roselli, V. Bortolussi, F. Nigro Imperiale, S. Venuta, V. Angelini, S. Cascinu, C. Volta, M. Musi, V. Guardasole, R. Ferraldeschi, L. Isa, Stefano Cascinu, F. Cognetti, M.L. Evangelista, E. Biondi, M.P. Sirgiovanni, C. Modenesi, V. Gebbia, D. Santini, E. Greco, E. Ferrazzi, M. Betti, F. Verderame, C. Bumma, G. Cicero, G. Pieri, G. Nastasi, A. Pessi, L. Patoia, S. Palazzo, M. Belli, C. Di Fonzo, Giuseppe Colucci, S. Cigolari, G. Fornarini, F. Ferraù, G. Rosati, A. Nuzzo, G. Porcile, P. Sozzi, A. Mozzicafreddo, M. Chetrì, B. Massidda, G. Luporini, A. Lembo, R. Carroccio, F. Testore, Enzo Ballatori, V. Bon-ciarelli, G. Ausili Cefaro, P. Marchetti, P. Berniolo, G. Filippelli, Enrico Cortesi, Salvatore Palazzo, A. Prosperi, G. Citone, M. Cremonesi, A. Peta, G. Rimondi, Giorgio Mustacchi, Francesco Di Costanzo, F. Marrocolo, R. Laricchiuta, R. Maurizi Enrici, D. Perrone, G. P. Iannello, Fausto Roila, A. Lavarello, L. Manzione, V. Lacava, G. Solina, P. Manente, A. Cioffi, R. Ceccherini, V. Sidoti, V. Picece, E. Recaldin, V. Tinessa, P. Giordani, M. D'Aprile, O. Bertetto, M. D'Amico, M. Serlenga, E. Vigevani, M. Mazzoli, Giovanni Mantovani, P. Marsilio, P. Rizzo, V. Mascia, G. Tonini, G. Carteni, Alberto Sobrero, B. Daniele, L. Milesi, Benedetta Ruggeri, G. Margutti, M. Botturi, M. Nicodemo, V. Silingardi, C. Iacono, A. Comandone, G. Colucci, P. Alessandroni, E. Zarra, G. Beretta, G. Reguzzoni, M. Turaz-za, L. Tonda, A. Rossi, G. Troccoli, S. Mosconi, G. Catalano, S. Bretti, T. Prantera, M. Destefanis, A. Sobrero, G. Cruciani, V. Sciacca, M. Marzola, P. Malacarne, M. Mandalà, L. Montalbetti, G. Tuveri, A Ruggiero, A. Zaniboni, G. Cetto, S. Spada, S. Barni, Roberto Labianca, C. Caroti, M.T. Ionta, C. Bressi
Publikováno v:
Tumori Journal. 91:472-476
Aims and Background Rarely are conclusions from clinical trials summarized in international consensus conferences and promptly transferred to patient care. The adjuvant therapy for colorectal cancer used in daily clinical practice in Italy is describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d0a699e849d960b649a6a8bece6fa4
https://doi.org/10.1177/030089160509100605
https://doi.org/10.1177/030089160509100605
Autor:
A. Guglielmi, Giovanni Luca Frassineti, Daniele Turci, R. Labianca, Enrico Cortesi, L. Gallo, M. A. Pessi, F. Grossi, E Recaldin, Alberto Sobrero, P Testore, C. Caroti, Carlo Aschele, A Ravaioli, M. Cirillo
Publikováno v:
British Journal of Cancer
We have reported that an alternating regimen of bolus and continuous infusion 5-fluorouracil (FU) was superior to bolus FU in terms of response rate and progression-free survival in advanced colorectal cancer. Biochemical modulation was an essential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a991d28e273a4a99c6ec20f7119c78e
https://doi.org/10.1054/bjoc.2001.1732
https://doi.org/10.1054/bjoc.2001.1732
Autor:
Gianluigi Cetto, Franco Bonetti, E. Recaldin, Q. Piubello, Giovanni Paolo Pollini, Rolando Nortilli, L. Sperotto, Monica Turazza, A. Corgnati, S. Modena, Andrea Bonetti, Anna Tomezzoli, Annamaria Molino, Erminia Manfrin, Rocco Micciolo, P. Spagnolli
Publikováno v:
Breast Cancer Research and Treatment. 45:241-249
Over the last few years, estrogen receptor determination by means of immunohistochemistry has been extensively used. The aim of this study was to compare this technique with estrogen receptor determination by means of dextran-coated charcoal, and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf38cb5ab15ffc4bfa6acfddc7bbbf9c
https://doi.org/10.1023/a:1005769925670
https://doi.org/10.1023/a:1005769925670
Autor:
Enzo Ballatori, S. Ricci, C. Dazzi, A. Scanu, S. Morana, R. Saltarelli, V. De Angelis, F. Montinari, M. G. Mascia, F. Salinaro, Anna Maria Angelone, M. Tonato, S. Lucchino, Fausto Roila, G. Grecchi, P. Alessandroni, G. Favalli, B. Rugerri, Francesco Cognetti, Andrea Antonuzzo, R. Gareri, G. Ciccarese, M. Clerico, M. T. Ionta, D. Donati, E. Recaldin, C. Basurto, B. Massidda, A. Contu, Maurizio Nicodemo, C. Zara, N. Olmeo, Pierfranco Conte, Antonella Mattei, F. Buzzi, G. Scagliotti, A. Nuzzo, G. Selvaggi, S. Tateo, A. Del Favero, M. C. Locatelli, A. Pazzola, Luca Galli, M. L. Bruno, S. Porrozzi, F Di Orio, M. A. Palladino, M. Picciafoco, V. Picece, Enrico Cortesi, P. Masiero
Publikováno v:
American journal of clinical oncology. 23(3)
To evaluate whether the incidence of emesis in patients undergoing cisplatin chemotherapy and receiving the standard antiemetic prophylaxis during daily clinical practice was similar to that obtained in antiemetic trials, a prospective study was carr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08e2758772995ba027174c96863ea31
https://pubmed.ncbi.nlm.nih.gov/10857891
https://pubmed.ncbi.nlm.nih.gov/10857891
Autor:
Piana E, M. Guaraldi, P. Preti, L. Busutti, Orazio Caffo, G. Ferrara, G. Palomba, V. Picece, G. Ambrosini, Franco Pannuti, G. Sarobba, G. Robustelli della Cuna, A. Petralia, G. Lelli, Antonio Farris, Elena Strocchi, M Raimondi, E Recaldin, Andrea Martoni
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 22(1)
Background : High dose Epirubicin (HD-EPI) (>90 mg/m 2 ) and Vinorelbine (VNR) demonstrated antitumor activity as single agent (about 20%) in the treatment of advanced NSCLC. This trial compares these two agents combined with cisplatin (CP). Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ed408a57e1c6048ad964ab6ab63de3
https://pubmed.ncbi.nlm.nih.gov/9869105
https://pubmed.ncbi.nlm.nih.gov/9869105
Autor:
Felice Pasini, A. Masotti, Giuseppe Pelosi, R. Mostacci, E. Recaldin, P. Spagnolli, Antonio Santo, Gianluigi Cetto
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 6(1)
Summary Background Immunocytochemistry has often been used to identify tumor cells in bone marrow aspirate (BMA) of SCLC patients in order to improve the results of conventional histomorphology. However, whether the detection of bone marrow microloca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62eac509da4278e58aa8ce7e55c0a2a9
https://pubmed.ncbi.nlm.nih.gov/7536032
https://pubmed.ncbi.nlm.nih.gov/7536032
Autor:
P Apostoli, E Recaldin, Roberto Leone, Andrea Bonetti, Gianluigi Cetto, Annamaria Molino, T. Franceschi
Publikováno v:
Scopus-Elsevier
The treatment of elderly patients with cancer may be difficult because of the narrow therapeutic index of antineoplastic drugs, the decline in the performance of organs and functions, and frequent comorbidity. In these patients, therapeutic drug moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbf65e4a005fcc2958b6b723f00cbd8
https://pubmed.ncbi.nlm.nih.gov/7846745
https://pubmed.ncbi.nlm.nih.gov/7846745
Autor:
F, Pasini, G, Pelosi, A, Santo, M, Zaninelli, R, Mostacci, A, Masotti, P, Spagnolli, E, Recaldin, G L, Cetto
Publikováno v:
Minerva medica. 85(9)
We have used immunocytochemistry to identify tumor cells in bone-marrow aspirates of 40 untreated patients with small cell lung cancer and we compared the results with conventional histomorphology. The monoclonal antibodies (MAbs) used were NCC-LU-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9e759371972e46bd13e89cbd1831408
https://pubmed.ncbi.nlm.nih.gov/7936364
https://pubmed.ncbi.nlm.nih.gov/7936364
Autor:
Teresa Cenacchi, T. Bertoldin, C. Farina, M. G. Fiori, G. Crepaldi, C. F. Azzini, R. Girardello, B. Bagozzi, R. Garuti, P. Vivaldi, G. Belloni, A. Bordin, M. Durando, M. Lo Storto, L. Bertoni, A. Battistoni, C. Cacace, P. Arduini, A. Bonini, M. P. Caramia, G. Vaglieri, A. Brusomini, G. Donà, A. March, N. Campi, P. Cannas, F. Casson, G. Cavallarin, M. Delia, G. Cristianini, O. Louvier, F. Mello, R. Fameli, N. Urbani de Gheltoff, O. De Candia, G. Nante, C. Cattoni, P. L. Forte, M. Loreggian, A. Targa, G. Mansoldo, G. Noro, A. Meggio, F. Pedrazzi, F. Bonmartini, C. Ruggiano, M. Peruzza, G. Olivari, E. Recaldin, C. Bellunato, G. Rigo, M. Marin, L. Marinangeli, A. Saracino, O. Miceli, G. Lovo, R. Scarpa, L. Battistello, E. Tomat, B. Bernava, P. Olivo, G. Verga, G. Merli, A. M. Zerman, R. Crivellaro, A. Vozza, G. R. Ziliotto, V. Favaretto, L. Allegro
Publikováno v:
Aging (Milan, Italy). 5(2)
This double-blind study assesses the therapeutic efficacy and the safety of oral treatment with phosphatidylserine (BC-PS) vs placebo (300 mg/day for 6 months) in a group of geriatric patients with cognitive impairment. A total of 494 elderly patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08625fdc1e4f46376da225772bf9c7e5
https://pubmed.ncbi.nlm.nih.gov/8323999
https://pubmed.ncbi.nlm.nih.gov/8323999